Janssen JW - Search Results

1

MYEOV, a gene at 11q13, is coamplified with CCND1, but epigenetically inactivated in a subset of esophageal squamous cell carcinomas.

Janssen JW, Imoto I, Inoue J, Shimada Y, Ueda M, Imamura M, Bartram CR, Inazawa J. Janssen JW, et al. J Hum Genet. 2002;47(9):460-4. doi: 10.1007/s100380200065. J Hum Genet. 2002. PMID: 12202983

2

Control of MYEOV protein synthesis by upstream open reading frames.

de Almeida RA, Heuser T, Blaschke R, Bartram CR, Janssen JW. de Almeida RA, et al. Among authors: janssen jw. J Biol Chem. 2006 Jan 13;281(2):695-704. doi: 10.1074/jbc.M511467200. Epub 2005 Nov 7. J Biol Chem. 2006. PMID: 16275643 Free article.

3

MYEOV: a candidate gene for DNA amplification events occurring centromeric to CCND1 in breast cancer.

Janssen JW, Cuny M, Orsetti B, Rodriguez C, Vallés H, Bartram CR, Schuuring E, Theillet C. Janssen JW, et al. Int J Cancer. 2002 Dec 20;102(6):608-14. doi: 10.1002/ijc.10765. Int J Cancer. 2002. PMID: 12448002

4

Rearrangement and expression of myeov and hst in NIH/3T3 transfectants: a caveat for the interpretation of DNA transfection analyses.

Brecht M, Steenvoorden AC, Luf S, Bartram CR, Janssen JW. Brecht M, et al. Among authors: janssen jw. Oncol Rep. 2007 May;17(5):1127-31. Oncol Rep. 2007. PMID: 17390055

5

A PvuII-polymorphism within the AXL gene on chromosome 19q13.1.

Linz U, Schleithoff L, Janssen JW, Bartram CR, Müller CR. Linz U, et al. Among authors: janssen jw. Hum Mol Genet. 1993 Apr;2(4):492. doi: 10.1093/hmg/2.4.492-a. Hum Mol Genet. 1993. PMID: 8099306 No abstract available.

6

Concurrent activation of a novel putative transforming gene, myeov, and cyclin D1 in a subset of multiple myeloma cell lines with t(11;14)(q13;q32).

Janssen JW, Vaandrager JW, Heuser T, Jauch A, Kluin PM, Geelen E, Bergsagel PL, Kuehl WM, Drexler HG, Otsuki T, Bartram CR, Schuuring E. Janssen JW, et al. Blood. 2000 Apr 15;95(8):2691-8. Blood. 2000. PMID: 10753852 Free article.

7

Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology.

Nakao M, Janssen JW, Flohr T, Bartram CR. Nakao M, et al. Among authors: janssen jw. Cancer Res. 2000 Jun 15;60(12):3281-9. Cancer Res. 2000. PMID: 10866322

8

Novel interaction partners of the TPR/MET tyrosine kinase.

Schaaf CP, Benzing J, Schmitt T, Erz DH, Tewes M, Bartram CR, Janssen JW. Schaaf CP, et al. Among authors: janssen jw. FASEB J. 2005 Feb;19(2):267-9. doi: 10.1096/fj.04-1558fje. Epub 2004 Nov 16. FASEB J. 2005. PMID: 15546961

9

Exon trap analysis of a NF1 splice-site mutation in a chronic myelomonocytic leukemia patient.

Ludwig L, Janssen JW, Bartram CR. Ludwig L, et al. Among authors: janssen jw. Leukemia. 1995 May;9(5):922-4. Leukemia. 1995. PMID: 7769857

10

Spectrum of transforming sequences detected by tumorigenicity assay in a large series of human neoplasms.

Janssen JW, Braunger J, Ballas K, Faust M, Siebers U, Steenvoorden AC, Bartram CR. Janssen JW, et al. Int J Cancer. 1999 Mar 15;80(6):857-62. doi: 10.1002/(sici)1097-0215(19990315)80:6<857::aid-ijc10>3.0.co;2-b. Int J Cancer. 1999. PMID: 10074918

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters